Running Interference: RNAi with Silence Therapeutics' Craig Tooman
Business Of Biotech
00:00
Introduction
Craig tomb enjoined silence therapeutics at c f o in january 20 21, and just recently stepped into the ceo chair there. He's been a c f o at aratona viom Therapeutics, icaria and enzon pharmacuticals. And for the past 11 years, hes served as principal at stockborn, providing strategic business and financial advisory services for companies. On today's episode of the business of biotec craig toman brings his deep wealth of biotEC leadership experience to the conversation.
Transcript
Play full episode
